Uranium Energy’s Costly Wyoming Ramp Overshadows $794M Cash Pile and Zero-Revenue Strategy

Uranium Energy’s decision to hoard its uranium inventory rather than book a single dollar of revenue has laid bare a growing tension between operational ambition and near-term financial pain. The company posted a net loss of $52.34 million, or 11 cents per share, for its fiscal third quarter — more than double the 5-to-7-cent loss analysts had penciled in. With zero sales from its core business, the loss was entirely self-inflicted, the result of management’s deliberate bet that waiting for higher spot prices will eventually pay off.

The company holds around 1.456 million pounds of U3O8 in unhedged, unsold inventory and refuses to sell into the current market. That stance props up the balance sheet in one sense — the firm is debt-free with $794 million in total liquidity, of which $488 million is pure cash — but it leaves the income statement empty. The strategy is clear: no forward sales, no hedging. Investors who want to ride the uranium price must do so through the stock, which has taken a beating.

Production, meanwhile, is ramping up, but at a cost that has spooked the market. The Christensen Ranch project in Wyoming delivered 32,195 pounds of uranium concentrate during the quarter, but operating costs hit nearly $55 per pound. Permitting delays in the state and higher local taxes drove expenses well above initial expectations. A second facility, Burke Hollow in South Texas, started output in April, giving Uranium Energy two of its three U.S. platforms online. The company’s Canadian Roughrider project is still in the feasibility study stage.

Should investors sell immediately? Or is it worth buying Uranium Energy?

The broader political backdrop remains supportive. Washington’s “Nuclear Dominance — 3 by 33” initiative aims to secure a domestic nuclear fuel supply chain by 2033, and a ban on Russian uranium imports is already in effect. Billions in new enrichment capacity investments are being announced across the sector. Uranium Energy is positioning itself as a direct beneficiary of that policy push, yet the market is focused on the near-term cost blowout.

The stock has sold off sharply. At around €9.18 to €9.21, it has lost roughly 34% over the past 30 days and sits nearly 47% below its January 2026 high of €17.34 (or the equivalent dollar high). The relative strength index hovers near 33.6, brushing the oversold threshold, and the shares trade more than 23% under their 50-day moving average of €11.97.

Goldman Sachs analyst Brian Lee responded by trimming his price target to $16 from $18, citing disappointing production and cost data. He maintained a buy rating, however, suggesting the selloff has gone too far. CEO Amir Adnani has promised improvement in the fourth quarter, arguing that higher output volumes will normalize unit costs. The company is also pushing ahead with its U.S. uranium conversion facility through subsidiary UR&C, with a detailed cost study expected in the first half of 2027. Whether the market will show patience in the meantime depends on one thing: when — and if — the spot uranium price finally turns higher.